Form 8-K - Current report:
SEC Accession No. 0001641172-25-018042
Filing Date
2025-07-07
Accepted
2025-07-07 17:25:33
Documents
13
Period of Report
2025-07-02
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 45697
  Complete submission text file 0001641172-25-018042.txt   258536

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE drma-20250702.xsd EX-101.SCH 3780
3 XBRL DEFINITION FILE drma-20250702_def.xml EX-101.DEF 26634
4 XBRL LABEL FILE drma-20250702_lab.xml EX-101.LAB 36717
5 XBRL PRESENTATION FILE drma-20250702_pre.xml EX-101.PRE 25258
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5853
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40739 | Film No.: 251108956
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)